Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Aratana Therapeutics, Inc.

NASDAQ: PETXHealthcare / Biotechnology / USA
4.42+0.2800+6.76%Vol 4 914 5991Y Perf -9.78%
Jan 18th, 2019 16:00
BID4.41 ASK4.42
Open4.20 Previous Close4.14
Pre-Market4.26 After-Trading4.42
 0.12 2.90%  - -%
Target Price
7.33 
Analyst Rating
Moderate Buy 1.75
Potencial %
65.84 
Finscreener Ranking
★★★★     54.36
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★★     45.74
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★★+     54.03
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)215 
Earnings Rating
Neutral
Price Range Ratio 52wk %
21.49 
Earnings Date
12th Mar 2019

Today's Price Range

3.984.47

 

52wk Range

3.677.16

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Month
-23.92%
3 Months
-17.54%
6 Months
-2.21%
1 Year
-9.78%
3 Years
49.83%
5 Years
-76.39%

Quotes

Name / TickerPriceChg.Chg.%
PETX4.420.28006.76
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.60
Current Ratio
3.20
Long Term Debt to Total Capital
0.02
Total Debt to Equity
0.23
Interest Coverage
-5.70
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
66.60
EBIT Margin
-45.00
EBITDA Margin
-42.70
Pre-tax Profit Margin
-3 671.10
Profit Margin
-19.96
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
1.96
PS Ratios
6.97
Price to Cash Flow
108.00
Price to Free Cash Flow
-8.90
Cash Flow Per Share
-0.52
Price to Tangible Book
3.47
Book Value per Share
2.23
Enterprise Value (in ths.)
181 710
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-43.14
ROE last 12 Months
-21.46
Return on Assets (5Y Avg)
-29.47
ROA last 12 Months
-15.23
Return on Capital (5Y Avg)
-33.62
ROC last 12 Months
-14.40
Return on invested Capital Q
7.31
Return on invested Capital Y
-35.93
Assets Turnover
0.10
Receivables Turnover
1.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
30 506
Revenue per Share
0.63
Revenue Growth 3 Years
221.14
Revenue Growth 5 Years
231.26
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.130.19246.15
Q02 2018-0.19-0.1426.32
Q01 2018-0.18-0.19-5.56
Q04 2017-0.23-0.1917.39
Q03 2017-0.26-0.2119.23
Q02 2017-0.29-0.2610.34
Q01 2017-0.34-0.340.00
Q04 2016-0.43-0.3518.60
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.12--
12/2018 FY-0.2547.92Positive
3/2019 QR-0.0811.11Positive
12/2019 FY-0.22-10.00Negative
Next Report Date12th Mar 2019
Estimated EPS Next Report-0.11
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume4 914 599
Shares Outstanding (in ths.)48 624
Trades Count5 691
Dollar Volume19 506 777
Avg. Volume1 589 098
Avg. Weekly Volume2 003 954
Avg. Monthly Volume1 164 409
Avg. Quarterly Volume667 888

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

61%39%

Bearish Bullish

62%38%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Hold
1 (25.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.75
Strong Buy
1.25
Strong Buy
1.25

There are no comments yet.

News